DC Chemicals

All products / DC70579

M3258
CAT. NO. DC70579

M3258

Pack sizes and prices

Pack sizePrice
10 mg$1,500 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

M3258 (M 3258) is a potent, reversible, highly selective and orally acitve LMP7 inhibitor with ceullar IC50 of 4.1 nM.M3258 does not inhibit other constitutive proteasome and immunoproteasome subunits (IC50>2.5 uM).M3258 demonstrated strong antitumor efficacy in multiple myeloma xenograft models.M3258 treatment led to a significant and prolonged suppression of tumor LMP7 activity and ubiquitinated protein turnover and the induction of apoptosis in multiple myeloma cells both in vitro and in vivo.M3258 showed superior antitumor efficacy in selected multiple myeloma and mantle cell lymphoma xenograft models compared with the approved nonselective proteasome inhibitors bortezomib and ixazomib.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC70579
Product nameM3258
CAS2285330-15-4
Molecular formulaC17H20BNO5
Molecular weight329.1554
Purity>98%
SMILESO=C(N[C@@H](Cc1coc2ccccc12)B(O)O)[C@@H]1C[C@H]2CC[C@@H]1O2

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — M3258 (DC70579)

Related research products

Browse newly added products